Home › Breast Cancer › NCT06966050

Multi-center MRD Registry for Inflammatory Breast Cancer

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Female or males ≥18 years of age with the ability to understand and sign a written
* Participants who have a clinical diagnosis of stage III or IV inflammatory breast cancer (IBC).
* Participants who are planning to have or already completed a minimum of one blood draw for Signatera testing, for which the result and clinical data can be deposited into the study database.
* Participants must be within eight months of diagnosis and have not undergone breast surgery for this diagnosis of breast cancer.
* Participants must be English-speaking.

Exclusion Criteria:

\-

About the study

To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.

What is being tested

• Quality-of-life Questionnaire (behavioral)

Sponsor: M.D. Anderson Cancer Center · Participants: 200 · Started: May 5, 2025

Contact the study team

• Sadia Saleem, MD · Phone: 281-566-1900
• Angela Alexander · Phone: 713-792-9137

Official record on ClinicalTrials.gov — NCT06966050

Locations in the U.S.

Conditions

• Breast Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.